Genomic Health (GHDX) Tops Q3 EPS by 7c
More News related to GHDX
- Genomic Health to Present at Piper Jaffray Health Care Conference
- Genomic Health (GHDX) Tops Q3 EPS by 7c
- Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress
- Trading Radar for 11/04: Cisco (CSCO), Comcast (CMCSA), Tyco (TEL), Molson Coors (TAP) Report
- Genomic Health to Announce Third Quarter 2009 Financial Results and Host Conference Call on Wednesday, November 4, 2009
More News related to Earnings
- Davenport Upgrades Heinz (HNZ) to Buy
- First Analysis Upgrades Advisory Board Company (ABCO) to Overweight
- Jefferies & Co Upgrades Energy XXI (EXXI) to Hold
- Morgan Stanley Upgrades Iowa Telecom (IWA) to Equalweight
- Fox-Pitt Upgrades Eaton Vance (EV) to Outperform
Genomic Health, Inc. (NASDAQ: GHDX) reports Q3 loss of $0.02, 7 cents better than the analyst estimate of ($0.09). Revenue for the quarter was $39.5 million, which compares to the estimate of $39.11 million.
Related Categories
EarningsStocks Mentioned
-0.24Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
